104 related articles for article (PubMed ID: 20079734)
1. Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding.
Sonoda K; Miyamoto S; Nakashima M; Wake N
Exp Cell Res; 2010 Jul; 316(11):1795-803. PubMed ID: 20079734
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of RCAS1 as a biomarker of uterine cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
[TBL] [Abstract][Full Text] [Related]
3. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.
Sonoda K; Miyamoto S; Yamazaki A; Kobayashi H; Nakashima M; Mekada E; Wake N
Cancer; 2007 Nov; 110(9):1979-90. PubMed ID: 17849467
[TBL] [Abstract][Full Text] [Related]
4. Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity.
Fukuda M; Tanaka A; Hamao A; Suzuki S; Kusama K; Sakashita H
Oncol Rep; 2004 Aug; 12(2):259-67. PubMed ID: 15254686
[TBL] [Abstract][Full Text] [Related]
5. Novel therapeutic strategies to target RCAS1, which induces apoptosis via ectodomain shedding.
Sonoda K
Histol Histopathol; 2011 Nov; 26(11):1475-86. PubMed ID: 21938684
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of RCAS1 as a biomarker of ovarian cancer.
Sonoda K; Miyamoto S; Yotsumoto F; Yagi H; Nakashima M; Watanabe T; Nakano H
Oncol Rep; 2007 Mar; 17(3):623-8. PubMed ID: 17273743
[TBL] [Abstract][Full Text] [Related]
7. RCAS1 is associated with ductal breast cancer progression.
Rousseau J; Têtu B; Caron D; Malenfant P; Cattaruzzi P; Audette M; Doillon C; Tremblay JP; Guérette B
Biochem Biophys Res Commun; 2002 May; 293(5):1544-9. PubMed ID: 12054692
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1.
Nakashima M; Sonoda K; Watanabe T
Nat Med; 1999 Aug; 5(8):938-42. PubMed ID: 10426319
[TBL] [Abstract][Full Text] [Related]
9. RCAS1 induced by HIV-Tat is involved in the apoptosis of HIV-1 infected and uninfected CD4+ T cells.
Minami R; Yamamoto M; Takahama S; Miyamura T; Watanabe H; Suematsu E
Cell Immunol; 2006 Sep; 243(1):41-7. PubMed ID: 17250817
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1.
Suehiro Y; Muta K; Nakashima M; Abe Y; Shiratsuchi M; Shiokawa S; Ikuyama S; Yoshikawa Y; Watanabe T; Nishimura J
Eur J Haematol; 2005 May; 74(5):365-73. PubMed ID: 15813909
[TBL] [Abstract][Full Text] [Related]
11. A disintegrin and metalloproteinase 9 is involved in ectodomain shedding of receptor-binding cancer antigen expressed on SiSo cells.
Sonoda K; Kato K
Biomed Res Int; 2014; 2014():482396. PubMed ID: 25177692
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
13. Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma.
Toyoshima T; Nakamura S; Kumamaru W; Kawamura E; Ishibashi H; Hayashida JN; Moriyama M; Ohyama Y; Sasaki M; Shirasuna K
J Oral Pathol Med; 2006 Jul; 35(6):361-8. PubMed ID: 16762017
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RCAS1 expression by RNA interference recovers T cell growth and proliferation.
Han Y; Qin W; Huang G
Cancer Lett; 2007 Nov; 257(2):182-90. PubMed ID: 17825484
[TBL] [Abstract][Full Text] [Related]
15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
16. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
Yu C; Krystal G; Dent P; Grant S
Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
[TBL] [Abstract][Full Text] [Related]
17. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
Jiménez E; Montiel M
J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
[TBL] [Abstract][Full Text] [Related]
19. The membrane molecule RCAS1 induces immune cell apoptosis via the RCAS1-RCAS1R pathway.
Zhang Y; Zhu J; Hong X; Zhou Y; Ren K; Shu X; Wang Q
Int J Mol Med; 2013 Jun; 31(6):1319-26. PubMed ID: 23563217
[TBL] [Abstract][Full Text] [Related]
20. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2005 Jun; 97(3):772-9. PubMed ID: 15943986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
